ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On February 28, 2023, HeartBeam, Inc. (the “Company”)
entered into a Securities Purchase Agreement (the “SPA”) with Maverick Capital Partners, LLC (the “Investor”),
pursuant to which the Company agreed to sell, up to $5,000,000 (the “Shares”) of the Company’s common stock, par value
$0.0001 per share (the “Common Stock”) at 75% of the average calculated Volume Weighted Average Price per share during a Drawdown
Pricing Period (as defined in the SPA). On March 7, 2023, the parties to the SPA entered into an Amendment to Securities Purchase Agreement
(the “SPA Amendment No. 1”) pursuant to which the parties agreed to reduce the total value of the Shares available for sale
from $5,000,000 to $4,000,000. On March 7, 2023, the Company issued a Draw Down Notice (as defined in the SPA) pursuant to the terms in
the SPA to the Investor for 200,105 Shares and the Company received gross proceeds of $500,000. The Shares are expected to be delivered
on March 9, 2023.
On February 28, 2023, in connection with the SPA, the Company entered
into a note purchase agreement (the “NPA”) with the Investor. Pursuant to the terms of the NPA, the Company agreed to sell,
up to $5,000,000 principal amount of notes of the Company, bearing interest at 6% per annum (the “Convertible Notes”). On
March 7, 2023, the parties to the NPA entered into a First Amendment to Note Purchase Agreement (the “NPA Amendment No. 1”,
together with the SPA Amendment No. 1, the “Amendments”) pursuant to which the parties agreed to reduce the principal amount
of the Convertible Notes available for sale from $5,000,000 to $4,000,000.
The total availability of the SPA plus NPA is up to $4 million and
can be a combination of both agreements.
On March 1, 2023, the Company issued a $500,000 Convertible Note to
the Investor pursuant to the NPA resulting in gross proceeds of $500,000, before deducting other expenses. On March 7, 2023, the Company
paid off $500,000 principal amount of the Convertible Note plus accumulated interest.
The Shares issued pursuant to the March 7, 2023 Draw Down Notice will
be sold by the Company to the Investor pursuant to a prospectus supplement, which will be filed with the Securities and Exchange Commission
(the “SEC”), in connection with a takedown from the Company’s effective shelf registration statement on Form S-3, which
was filed with the SEC on February 2, 2023 and subsequently declared effective on February 10, 2023 (File No. 333-269520).
The foregoing description of the Amendments is
a summary and is qualified in its entirety by reference to the provisions thereof, a copy of which is attached to this Current Report
as Exhibit 10.1 and 10.2 respectively, which are incorporated by reference herein.